Case Reports in Pathology

Case Reports in Pathology / 2019 / Article

Case Report | Open Access

Volume 2019 |Article ID 3826521 | 6 pages | https://doi.org/10.1155/2019/3826521

Primary Chordoma of the Nasopharynx: A Rare Case Report and Review of the Literatures

Academic Editor: Piero Tosi
Received22 Apr 2019
Accepted06 Aug 2019
Published23 Sep 2019

Abstract

Primary chordoma of the nasopharynx is an extremely rare malignant tumor of notochordal origin in the extra-osseous axial skeleton. It presents as a soft tissue mass without involvement of the skull base bone (clivus) and may mimic other lesions of the nasopharynx. A 26-year-old male patient is presented with nasal obstruction and congestion for the last 3 years. Physical and radiological examination revealed a mass in the naso-oropharyngeal region. It was suspected to be a cystic mass or abscess on radiological imaging. However, histopathological examination revealed a chordoma. We review all 20 cases of primary nasopharyngeal chordoma reported previously in the literature. Nasopharyngeal chordoma should be considered in the differential diagnosis of nasopharyngeal mass due to its unspecific appearance on clinical and radiology examination.

1. Introduction

Chordoma is a rare malignant bone tumor that occurs in any site along the course of embryogenic notochord and typically in the axial skeleton [1]. It affects males twice compared to females, and the age range is 40–60 years [1, 2]. The topographic distribution of chordoma includes sacrococcygeal (50%), cranio-cervical/spheno-occipital (35%), and thoraco-lumbar spine (15%). Cranio-cervical chordomas most often involve the dorsum sellae, the clivus, and rarely the nasopharynx [2]. Unusual locations had been reported including the mandible and the maxilla (dental chordoma), some also with nasal and paranasal presentations [3].

Histologically, the hallmark of chordoma is the presence of large physaliphorous cells (Greek: physalis: bubbles) with vesicular nuclei embedded in a homogenous, intercellular substance. The vacuoles contain either mucinous substance or glycogen. The intercellular substance is considered as partly the result of cell secretion and in part of products of cell degeneration [4].

Chordoma is categorized into 3 types: Classical or conventional chordoma, which is rich in physaliphorous cells, and is the most frequent type of chordoma; chondroid chordoma, resembling both chordoma and chondrosarcoma; and dedifferentiated chordoma featuring sarcomatous areas which are comprised of spindle-shaped and polygonal cells, and is the most aggressive type of chordoma [5].

Immunohistochemically, the notochordal cells strongly express cytokeratin but weakly vimentin in the earlier developmental stages of the foetus. In later developmental stages, it shows distinct increase in vimentin expression and a slight decrease in cytokeratin expression [6]. Chordoma may also express epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), S100 protein, alpha 1-antichymotrypsin, and lysozyme [7]. Brachyury had been proposed as the most specific diagnostic marker of chordoma’s neoplastic cells since it is a transcription factor which is required for notochord development during embryogenesis [8].

Herein we report a case of primary chordoma of the nasopharynx, its characteristics, and a review of previously reported cases.

2. Case Presentation

A 26-year-old man was admitted to the ear, nose, and throat department of our hospital with nasal obstruction and congestion of 3 years duration. There was no history of headache, epistaxis, visual changes, or cranial nerve palsy/paresis.

Physical examination showed a mass in naso-oropharyngeal region with anterior displacement of the uvula. Radiological examination by axial, coronal, and sagittal MSCT with and without contrast confirmed the presence of a round-large lobulated mass in naso-oropharyngeal region, approximately 5 × 6 cm with well-defined margin without involvement of the clivus (Figure 1). It was interpreted as a naso-oropharyngeal cystic mass, possibly a naso-oropharyngeal abscess. Chest X-ray was unremarkable. Laboratory workup revealed that all haematological and biochemical parameters were within normal limits.

Biopsies were taken from different parts of the mass (right and left nasopharynx and oropharynx) but they were superficial and did not reach the tumor itself. Histologically, they showed nonspecific chronic inflammation. The patient was treated with antibiotic and anti-inflammatory drugs, without any clinical improvement.

A deep biopsy from the mass was eventually obtained, and it revealed a chordoma of the nasopharynx. The patient underwent surgery to excise the mass with trans-palatal rhinotomy approach, under general anaesthesia. Approximately 30 cc of fragmented tissue was received. Macroscopically, the tumor tissue was firm and lobulated, some was covered by brownish white mucosa. Microscopic examination showed cords and lobules of physaliphorous cells embedded within extensive myxoid stroma, separated by fibrous septa. Some of tumor cells already invaded adjacent skeletal muscle. The physaliphorous cells were variable in size, with abundant eosinophilic to clear cytoplasm, some were vacuolated, with prominent vesicular nuclei. Other tumor cells were small with pyknotic nuclei. Mitotic figures were inconspicuous (Figure 2).

The immunohistochemical studies revealed positive cytoplasmic staining for cytokeratin and vimentin. Meanwhile, expression of S100 was slightly weaker (Figure 3). Immunostaining of brachyury was not performed since it was not available in any of the pathology laboratories in our country. After surgery, the patient showed excellent recovery with no other complication. The patient had been closely followed up at the ENT outpatient clinic.

3. Discussion

Chordoma is a rare malignant bone tumor, primarily involving both ends of the axial skeleton, and arise from the remnant of the notochord. It was first described by Virchow in 1857 as a tumor made up of vacuolated or physaliphorous cells derived from rests of embryonic notochord along the midline central nervous system axis [9].

The notochord is a rod-like aggregate of cells extending the entire length of the embryo on the midline, ventral to the developing neural tube. The embryonic notochord degenerates early in fetal development after being surrounded by sclerotome mesenchymal cells and remains as the nucleus pulposus within intervertebral disc. However, in some cases residual notochord cells remain outside the inter-vertebral disc and may become neoplastic [10].

Primary nasopharyngeal chordoma arises in the extraosseous nasopharyngeal soft tissues and may or may not have a smaller intraosseous component along the course of the medial basal canal. The medial basal canal is considered the cephalad exit tract of the notochord as it moves from its intraclival location ventrally into the midline nasopharyngeal soft tissues [3]. Chordomas arising from the skull base/clivus with extension into the nasopharynx area are excluded in the list of primary nasopharyngeal chordomas [1]. They are preferably diagnosed as clival chordomas presenting as nasopharyngeal mass [11, 12].

To the best of our knowledge, only 20 cases of primary nasopharyngeal chordoma had been previously reported, with 5 of them presented without any bone involvement [1, 3, 1319]. We summarize the clinical, radiological, and histological features of patients with nasopharyngeal chordoma in Table 1, including the current case.


NoReferencesAge/SexChief complaintRadiologyBony involvementDifferential diagnosisTumor size (cm)GrossPathology

1Handosa Bey, 1949 [13]16/FNasal obstruction for 2.5 years, headacheMass in the skull base (sphenoid-base), filling nasophryngeal cavityBony trabecula involvementOsteoclastomaN/ASoft friable tissueClassic type
2Seltzer et al., 1961 [14]24/FSix months of difficulty in swallowing, strangling sensation, moderate pain localized in the back of the throat, nasal speechLarge lobular and tender mass over the left nasopharyngeal floorNo erotion, nor other involvement of boneRetropharyngeal abcess, infected cyst of the pharynx4 × 4Lobulated, soft, whitish mass with a cleft in the centerClassic type
3Hingorani et al., 1970 [15]62/MThree months of progresive left-sided nasal obstructionLarge nasopharyngeal mass sitting on the sphenoidal sinusSome bony spiculation and erosionChondrosarcoma cannot be positively excludedN/ALobulated, fleshy, friable, brownish greyChondroid type
4Maru et al., 1988 [16]52/MNine months of nasal obstruction, bilateral hearing impairmentA huge soft tissue mass completely occupying the nasoppharyrtx and protruding into the orophaxynxNo bone involvementChondroma, Chondrosarcoma8 × 6A globular smooth massClassic type
5Maru et al., 1988 [16]20/MPainful swelling of the right side of the face for 4 monthsSoft-tissue mass in the right maxillary antrum with bone destruction of the medial, and anterolateral walls and roofInvolving anterolateral wall ofthe right maxilla, alveolar margin, gingivo-buccal sulcus and hard palatechondrosarcomaN/ASoft-tissue mass with bone destructionClassic type
6Boyle et al., 1954 [17]43/MDouble vision for 12 months, nasal obstruction for 3 months, and severe periotbital headaches and deafnessMass instilled into the nose until sphenoid sinusBone destruction at the base of the skullNasopharyngeal carcinoma, adenocarcinomaN/AHard and smooth lobulated tumour in a mucinous substanceClassic type
7Hampal et al., 1992 [18]80/FSix months of dysphagia for solids and weight lossWell circumscribed mass in the left parapharyngeal spaceAbsence of bony/spine involvementNasopharyngeal carcinoma4 × 4Greyish-white with a lobulated surface and gelatinous on the cut surfaceClassic type
8Wright et al., 1967 [19]16/MComplete bilateral nasal obstruction and nose bleeds for several monthsSoft tissue swelling filling the nasopharynxNo bone involvementNasopharyngeal carcinoma8 × 2Swelling massClassic type
9Wright et al., 1967 [19]26/FIncreasing bilateral nasal obstructionLarge soft tissue mass filling the nasopharynxNo bone involvementNasopharyngeal carcinomaN/ALarge tumor massClassic type
10Wright et al., 1967 [19]53/FRight-sided headaches for 8 months, diplopia, numbness of the right cheek, tongue and gums, tinnitus, and deafness on the right sideMass in the nasopharynx with erosion part of the right middle cranial fossa and pituitary fossaExtension of erosion into the left middle cranial fossa and petrous apexNasopharyngeal carcinomaN/ALarge tumor massClassic type
11Wright et al., 1967 [19]52/MLeft frontal pain and a drooping upper eyelidRaised intracranial pressure with erosion of the pituitary fossa and destruction of the sphenoid and adjacent left ethmoid cellsDestruction of sphenoid, ethmoid and pituitary fossaNasopharyngeal carcinomaN/AFirm blue cyctic swellingClassic type
12Nguyen et al., 2009 [3]8/FNasal obstruction, dryness of the mouth, difficulty in breathing,Midline lobular and expansile mass with internal septation centered in the nasopharynxBony lytic changes along the anterior surface of the clivus (5/5)Nasopharyngeal carcinoma, NonHodgkin lymphomaN/ALobulatedClassic type
13Nguyen et al., 2009 [3]65/F
14Nguyen et al., 2009 [3]56/M
15Nguyen et al., 2009 [3]53/M
16Nguyen et al., 2009 [3]32/F
17Yan et al., 2010 [1]13/MOne to five years of nasal obstruction, headache and hearing loss (2/4)Lobular and expansile nasopharyngeal mass with irregular intra tumor calsificationNo bony involvement into the clivusNasopharyngeal Carcinoma, Juvenile Nasopharyngeal Angiofibroma2.5–8.2Lobulated, well defined with intra tumor septaClassic type
18Yan et al., 2010 [1]31/M
19Yan et al., 2010 [1]38/M
20Yan et al., 2010 [1]66/F
21Present case26/MThree years of nasal obstruction and congestionLobulated naso-oropharyngeal mass with displacement of uvula anteriorlyNo bony involvement into the clivusNaso-oropharyngeal cystic mass/abcess.5 × 6Lobulated, brownish white, some parts with black spotClassic type

N/A = Not Available

Primary nasopharyngeal chordoma commonly occurs in young adults with an average age of 39.6 years, ranging from 8 to 80 years. It affects males (57.1%) more than females (42.8%) with a male to female ratio of 1.3 : 1. The main clinical presentation is nasal obstruction, reported in 16 cases (76.2%). Other symptoms include hearing impairment, headache, difficulty in swallowing, dryness of the mouth, nasal bleeding, diplopia, numbness, dropping of upper eye lid, difficulty in breathing, and nasal speech. Almost all patients with primary nasopharyngeal chordoma show unremarkable laboratory findings and normal general physical examination. The tumor size ranged from 2.5 to 8.2 cm and all were lobulated. Chondroid chordoma was found in a single case with progressive manifestation within 3 months prior to diagnosis, and chondrosarcoma cannot be excluded in the differential diagnosis. Twenty cases were identified as classical chordoma (95.2%) and 6 cases (28.6%) showed slow growing tumors, with clinical manifestation observed within 6 months up to 5 years prior to the diagnosis. 5 cases had no further information regarding the onset of their clinical manifestation.

Histopathologically, 20 cases (including the current case) were classical chordomas showing numerous physaliphorous cells arranged in cord or lobules with myxoid stroma separated by fibrous tissue, meanwhile 1 case was chondroid variant, showing chondroid differentiation resembling chondrosarcoma [5]. Radiologically, classical and chondroid chordoma can be misdiagnosed with cyst, abscess, nasopharyngeal angiofibroma, or even nasopharyngeal carcinoma. Clinically, unlike malignant lesion, benign lesion do not progress in size in a short time, or invade or destroy the surrounding tissues. Cystic lesions are identified by single or multiple spaces lined with cuboidal or flattened epithelial cells [20]. Nasopharyngeal abscess formation is characterized by prominent necrotic area, infiltrated by numerous inflammation cells, specially leucocytes [21]. Angiofibroma showed proliferation of fibroblasts along with numerous blood vessels [22]. Lastly, nasopharyngeal carcinoma is characterized by islands of epithelial cells which consisted of round, oval to spindle atypical cells, infiltrating to surrounding area [23]. Up to now, dedifferentiated type of primary nasopharyngeal chordoma has not been reported yet.

In all cases of reported nasopharyngeal chordomas, metastasis was not observed. However, there had been reports of cases of chordoma that metastasized to the peritoneum, pleura [24], liver [1, 24], lung, bone, soft tissue, skin [1, 2, 24], and lymph node [12].

This case report was interesting on several counts. We experienced some difficulties during the pre-operative diagnosis due to the nonspecific features of chordoma on clinical and radiological examinations. Moreover, particular location of the tumor was difficult to be reached and biopsied. Those factors resulted in delayed accurate diagnosis. Because of the location in nasopharynx region, the differential diagnosis of chordoma should be made from other nasopharyngeal masses. Although CT and MRI features are nonspecific, they may be suggestive of chordoma including midline location, expansible or lobular soft tissue mass with well-defined margin. Other nasopharyngeal malignancies may destroy clival bone but do not demonstrate this midline tract. CT is ideal for evaluating the bony involvement, whereas MRI is useful in evaluating the surrounding soft tissues and extension into adjacent structures [3]. Chordoma is considered to have poor sensitivity of radiotherapy and chemotherapy; however, surgery was shown as the treatment of choice [19, 24].

4. Conclusion

Primary chordoma of the nasopharynx is a rare but an important lesion to be considered when a midline nasopharyngeal mass is found with or without involvement of clival sinus tract. It has no specific appearance on clinical and radiological examination. Obtaining the right biopsy material is required for proper histopathological diagnosis of the tumor.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. Z. Y. Yan, B. T. Yang, Z. C. Wang, J. F. Xian, and M. Li, “Primary chordoma in the nasal cavity and nasopharynx: CT and MR imaging findings,” American Journal of Neuroradiology, vol. 31, no. 2, pp. 246–250, 2010. View at: Publisher Site | Google Scholar
  2. R. Chugh, H. Tawbi, D. R. Lucas, J. S. Biermann, S. M. Schuetze, and L. H. Baker, “Chordoma: the nonsarcoma primary bone tumor,” The Oncologist, vol. 12, no. 11, pp. 1344–1350, 2007. View at: Publisher Site | Google Scholar
  3. R. P. Nguyen, K. L. Salzman, H. E. Stambuk, A. T. Ahuja, and H. R. Harnsberger, “Extraosseous chordoma of the nasopharynx,” American Journal of Neuroradiology, vol. 30, no. 4, pp. 803–807, 2009. View at: Publisher Site | Google Scholar
  4. X. Gui, N. H. Siddiqui, and M. Guo, “Physaliphorous cells in chordoma,” Archives of Pathology & Laboratory Medicine, vol. 128, no. 12, pp. 1457-1458, 2004. View at: Publisher Site | Google Scholar
  5. Z. Mou and Z. Liu, “Primary chordoma of the nose,” Chinese Medical Journal, vol. 116, no. 1, pp. 154–156, 2003. View at: Google Scholar
  6. M. S. Babic, “Development of the notochord in normal and malformed human embryos and fetuses,” The International Journal of Developmental Biology, vol. 35, no. 3, pp. 345–352, 1991. View at: Google Scholar
  7. J. M. Meis and A. A. Giraldo, “Chordoma. An immunohistochemical study of 20 cases. ,” Archives of Pathology & Laboratory Medicine, vol. 112, no. 5, pp. 553–556, 1988. View at: Google Scholar
  8. V. Barresi, A. Ieni, G. Branca, and G. Tuccari, “Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers,” Disease Markers, vol. 2014, Article ID 514753, 7 pages, 2014. View at: Publisher Site | Google Scholar
  9. J. Alshammari, P. Monnier, R. T. Daniel, and K. Sandu, “Clival chordoma with an atypical presentation: a case report,” Journal of Medical Case Reports, vol. 6, no. 1, Article ID 410, 2012. View at: Publisher Site | Google Scholar
  10. T. Yamaguchi, H. Watanabe-Ishiiwa, S. Suzuki, Y. Igarashi, and Y. Ueda, “Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors,” Modern Pathology, vol. 18, no. 7, pp. 1005–1010, 2005. View at: Publisher Site | Google Scholar
  11. S. P. Kataria, A. Batra, G. Singh, S. Kumar, and R. Sen, “Chordoma of skull base presenting as nasopharyngeal mass,” Journal of Neurosciences in Rural Practice, vol. 4, no. 5, 95 pages, 2013. View at: Publisher Site | Google Scholar
  12. B. B. Jain, S. Datta, S. G. Roy, and U. Banerjee, “Skull base chordoma presenting as nasopharyngeal mass with lymph node metastasis,” Journal of Cytology, vol. 30, no. 2, pp. 145–147, 2013. View at: Publisher Site | Google Scholar
  13. A. S. Handousa Bey, “Clinical records. A case of nasopharyngeal chordoma,” The Journal of Laryngology and Otology, vol. 63, no. 1, pp. 31–33, 1949. View at: Publisher Site | Google Scholar
  14. A. P. Seltzer, “Nasopharyngeal chordoma. A case report,” Journal of the National Medical Association, vol. 53, pp. 41-42, 1961. View at: Google Scholar
  15. R. K. Hingorani, “Nasopharyngeal chordoma,” The Journal of Laryngology and Otology, vol. 84, no. 12, pp. 1281–1286, 1970. View at: Publisher Site | Google Scholar
  16. Y. K. Maru and S. Jain, “Chordoma of the nasopharynx and maxilla,” Indian Journal of Otolaryngology, vol. 40, no. 3, pp. 107–109, 1988. View at: Google Scholar
  17. T. M. Boyle and H. G. Frank, “The management of nasopharyngeal chordoma by repeated irradiation,” The Journal of Laryngology & Otology, vol. 80, no. 5, pp. 533–535, 1966. View at: Publisher Site | Google Scholar
  18. S. Hampal, L. M. Flood, and R. A. Jones, “Chordoma of the parapharyngeal space,” The Journal of Laryngology and Otology, vol. 106, no. 6, pp. 549–552, 1992. View at: Publisher Site | Google Scholar
  19. D. Wright, “Nasopharyngeal and cervical chordoma–some aspects of their development and treatment,” The Journal of Laryngology & Otology, vol. 81, no. 12, pp. 1337–1355, 1967. View at: Publisher Site | Google Scholar
  20. K. Sekiya, M. Watanabe, R. N. Nadgir et al., “Nasopharyngeal cystic lesions: tornwaldt and mucous retention cysts of the nasopharynx: findings on MR imaging,” Journal of Computer Assisted Tomography, vol. 38, no. 1, pp. 9–13, 2014. View at: Publisher Site | Google Scholar
  21. D. C. Fitzgerald, “Nasopharyngeal abscess and facial paralysis as complications of petrous apicitis: a case report,” Ear Nose & Throat Journal, vol. 80, no. 5, pp. 305–312, 2001. View at: Publisher Site | Google Scholar
  22. C. Sanchez-Romero, R. Carlos, J. P. Diaz Molina, L. D. R. Thompson, O. P. de Almeida, and A. Rumayor Pina, “Nasopharyngeal angiofibroma: a clinical, histopathological and immunohistochemical study of 42 cases with emphasis on stromal features,” Head and Neck Pathology, vol. 12, no. 1, pp. 52–61, 2018. View at: Publisher Site | Google Scholar
  23. L. D. R. Thompson, “Update on nasopharyngeal carcinoma,” Head and Neck Pathology, vol. 1, no. 1, pp. 81–86, 2007. View at: Publisher Site | Google Scholar
  24. R. P. Kamrin, T. L. J. N. Potanos, and J. L. Pool, “An evaluation of the diagnosis and treatment of chordoma,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 27, no. 2, pp. 157–165, 1964. View at: Publisher Site | Google Scholar

Copyright © 2019 Ery Kus Dwianingsih et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

624 Views | 308 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.